Aromatase inhibitors (AI) have proven to be effective in women with hormone receptor-positive breast cancer (BC). However, the frequent appearance of stiffness and arthralgias following treatment with AIs results in a worsening of their quality of life and leads to consultations…
The Clínica Sant Josep (CSJ), managed by the Althaia Foundation, and the Dexeus Mujer group have signed an agreement to implement a new healthcare model at this hospital located in central Catalonia, which offers highly specialised medical care…
A multidisciplinary group of researchers at Dexeus Mujer have carried out an extensive study to evaluate the impact of adenomyosis in women undergoing IVF treatment. In total, a sample of 3503 patients undergoing their first…
To assess the safety and efficacy of adjuvant add-on treatments offered to improve assisted reproductive outcomes, the European Society of Human Reproduction and Embryology (ESHRE) appointed a multidisciplinary working group of clinicians…
The Fundación Dexeus Mujer awards Ly Dumas, president of the Jean-Félicien Gacha Foundation and grant to an ISGlobal researcher for its work in favour of women’s health in Africa
Last October we celebrated the 25th anniversary of the Master’s Degree in Reproductive Biology and Assisted Reproductive Technology, offered jointly by Dexeus Mujer and the Department of Cell Biology, Physiology and Immunology of the Autonomous University of Barcelona (UAB).
Aromatase inhibitors (AI) have proven to be effective in women with hormone receptor-positive breast cancer (BC). However, the frequent appearance of stiffness and arthralgias following treatment with AIs results in a worsening of their quality of life and leads to consultations…
The Clínica Sant Josep (CSJ), managed by the Althaia Foundation, and the Dexeus Mujer group have signed an agreement to implement a new healthcare model at this hospital located in central Catalonia, which offers highly specialised medical care…
A multidisciplinary group of researchers at Dexeus Mujer have carried out an extensive study to evaluate the impact of adenomyosis in women undergoing IVF treatment. In total, a sample of 3503 patients undergoing their first…
To assess the safety and efficacy of adjuvant add-on treatments offered to improve assisted reproductive outcomes, the European Society of Human Reproduction and Embryology (ESHRE) appointed a multidisciplinary working group of clinicians…
The Fundación Dexeus Mujer awards Ly Dumas, president of the Jean-Félicien Gacha Foundation and grant to an ISGlobal researcher for its work in favour of women’s health in Africa
Last October we celebrated the 25th anniversary of the Master’s Degree in Reproductive Biology and Assisted Reproductive Technology, offered jointly by Dexeus Mujer and the Department of Cell Biology, Physiology and Immunology of the Autonomous University of Barcelona (UAB).
The European Society of Human Reproduction and Embryology (ESHRE) has recognised our Department as an accredited centre to provide training in the speciality of Reproductive Medicine. It is the only centre in Spain that currently has this accreditation…
The current prevalence of superficial endometriosis is poorly understood, although it is the most common subtype of endometriosis. Moreover, its diagnosis is difficult, as the appearance and characteristics of the…
A group of researchers from the Reproductive Medicine Unit of our centre have conducted a large study to assess whether the presence of high levels of progesterone in patients on hormone replacement therapy could have a…
Since the beginning of IVF, embryo selection has been based on morphology. Despite the emergence of new non-invasive selection methods, the majority of fertility centres continue to rely on morphological criteria.
DEXEUS CAMPUS
Gran Vía de Carles III 71-75
08028 Barcelona
campus@dexeus.com
(+34) 93 227 47 09
